PT  - JOURNAL ARTICLE
AU  - Lang, Henry
AU  - Loudermilk, Elaine N.
AU  - Clark, W. Andrew
AU  - Marrs, Jo-Ann
AU  - Joyner, T. Andrew
AU  - Wang, Liang
AU  - Gerber, Kathryn S.
AU  - Alamian, Arsham
TI  - INFLAMMATORY MARKERS AND BODY MASS INDEX AMOUNG HISPANIC CHILDREN
AID  - 10.1101/2023.07.21.23293009
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.07.21.23293009
4099  - http://medrxiv.org/content/early/2023/07/24/2023.07.21.23293009.short
4100  - http://medrxiv.org/content/early/2023/07/24/2023.07.21.23293009.full
AB  - Background and Objectives Body mass index (BMI) is inversely proportional with adiponectin levels among adults, while insulin, C-reactive protein (CRP), interleukin 6 (IL-6), resistin, and tumor necrosis factor-alpha (TNF-α) have been linked with elevated BMI. The role and relation of these biomarkers with BMI among Hispanic pediatric populations are less known. Thus, the objective of this cross-sectional study was to examine the association of inflammatory markers with the odds of overweight/obesity while controlling for several sociodemographic factors among a Hispanic youth population of Northeast Tennessee.Methods Height, weight, demographic information, and blood samples were collected from 107 Hispanic children aged 2 to 10 years recruited at a large community health center in 2015-2016 in Northeast Tennessee. Data for this research were accessed and analyzed in 2022. Multivariable logistic regression was conducted to assess the relations between adiponectin, insulin, resistin, CRP, TNF-α, and IL-6, and overweight/obesity vs. having a healthy (normal) weight.Results Adiponectin levels were significantly lower among overweight/obese Hispanic children (p = 0.0048) compared to healthy weight children. The odds of overweight/obesity decreased by 4% for every one-unit increase in serum adiponectin. Insulin levels were significantly higher among overweight/obese Hispanic children (p = 0.0048) compared to healthy weight children (p=0.0008). The odds of overweight/obesity increased by 7% for every one-unit increase in serum insulin. Resistin, IL-6, TNF-α, and CRP were not significantly associated with overweight/obesity in this population.Conclusion Adiponectin behaves similarly in Hispanic youth as it does in other pediatric populations, possibly making it a valuable marker when examining metabolic health status in this population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAA and WAK received a diversity research grant (E210029) from the Tennessee Board of Regents (https://www.tbr.edu/) in support of this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions or assertions herein are the views of the authors and do not necessarily reflect the official policy or position of the U.S. Air Force, the Department of Defense, or the U.S. Government.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study received approval from the East Tennessee State University Human Subject Research Ethics Committee (IRB#: 0414.16s). Written consent was obtained from all study participants.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesN/A